Philippe De Backer nag-retweet

Misconception: patents held by biopharma companies would lead to limited access to new #medicines and high prices. Read how it really works:
NL
pharma.be/nl/media/nieuw…
FR
pharma.be/fr/medias/actu…
@debackerphil #Innovation #IP #patents #Research #Belgium
English





















